OPC Pharmaceutical JSC

OPC Pharmaceutical JSC Net Margin

The Net Profit Margin of OPC Pharmaceutical JSC (OPC.VN) as of Nov 4, 2026 is 9.40 %. In the previous year, Net Profit Margin was 10.31 % — a change of -8.83% (lower).

Net Margin

9.40 %

YoY

-8.83%

Last updated:

Net Profit Margin of OPC Pharmaceutical JSC is 2024 9.40 % . Net Profit Margin of OPC Pharmaceutical JSC was 2023 10.31 % . It decreases by -8.83% lower compared to the previous year.

For OPC Pharmaceutical JSC, the net margin of 9.4% is broadly stable versus 8.9% a few years ago.

The OPC Pharmaceutical JSC Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2013
0.10 VND
Jan 1, 2014
9.62 VND
Jan 1, 2015
9.54 VND
Jan 1, 2016
8.89 VND
Jan 1, 2017
8.28 VND
Jan 1, 2018
8.78 VND
Jan 1, 2023
10.31 VND
Jan 1, 2024
9.40 VND
The OPC Pharmaceutical JSC Net Margin history
YEARNet MarginYoY
9.40 %-8.83%
10.31 %+17.38%
8.78 %+5.99%
8.28 %-6.81%
8.89 %-6.79%
9.54 %-0.91%
9.62 %+9,545.02%
0.10 %-9.67%
0.11 %-10.09%
0.12 %-13.05%
0.14 %+7.57%
0.13 %-7.19%
0.14 %-23.76%
0.19 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

OPC Pharmaceutical JSC Stock analysis

What does OPC Pharmaceutical JSC do? OPC Pharmaceutical JSC manufactures and markets pharmaceutical products derived from natural materials cultivated and processed at its facilities. The company produces and trades pharmaceutical chemicals and supplies, functional food, wine, and bottled water. Its primary revenue streams include the sale of manufactured drugs, pharmaceutical chemicals, and functional food to healthcare providers and consumers. The company also engages in wholesale trading of pharmaceutical products and supplies. OPC Pharmaceutical JSC's product portfolio includes drugs made from natural pharmaceutical materials, pharmaceutical chemicals, functional food, wine, and bottled water. The company markets these products through its own distribution channels, targeting both medical institutions and end consumers. The firm's operations in wine distillery and bottled water manufacturing complement its pharmaceutical business, providing additional revenue streams. The company's manufacturing and marketing activities focus on natural pharmaceutical materials, pharmaceutical chemicals, and functional food. Its sales are directed towards healthcare providers for drug distribution and to consumers for functional food, wine, and bottled water. The dissolution of OPC EXIM Real Estate Joint Stock Company in 2014 does not affect its core pharmaceutical and related product lines. OPC Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OPC Pharmaceutical JSC stock

Net Profit Margin of OPC Pharmaceutical JSC is 9.40 % in 2024.

Net Profit Margin of OPC Pharmaceutical JSC changed from 10.31 % to 9.40 %, representing a -8.83% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin OPC Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's OPC Pharmaceutical JSC with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — OPC Pharmaceutical JSC

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — OPC Pharmaceutical JSC